Totally implantable venous catheters for chemotheraphy: Experience in 500 patients

Sao Paulo Medical Journal

Volumn 122, Issue 4, 2004, Pages 147-151

  Wolosker, Nelson ^a,b   Yazbek, Guilherme ^a   Nishinari, Kenji ^a   Caetano Malavolta, Luiz ^a   Munia, Marco Antonio ^a   Langer, Marcel ^a   Zerati, Antonio Eduardo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b NONE   (Brazil)

Author keywords

Catheterization; Central venous catheterization; Drug therapy; Infection; Thrombosis

Indexed keywords

ANTINEOPLASTIC AGENT; STREPTOKINASE; VANCOMYCIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLADDER CANCER; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; DEVICE REMOVAL; DIGESTIVE SYSTEM CANCER; FEMALE; HEMATOMA; HUMAN; INFECTION; INTRAVENOUS CATHETER; JUGULAR VEIN; LONG TERM CARE; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PROSTATE CANCER; SAFETY; SKIN CANCER; SOFT TISSUE CANCER; TESTIS CANCER; THROMBOPHLEBITIS; TREATMENT OUTCOME; URINARY TRACT CANCER; UTERUS CANCER; VASCULAR ACCESS; VEIN OCCLUSION;

EID: 9144252162     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802004000400003     Document Type: Article

References (36)

1. Broviac JW, Cole JJ, Scribner BH, A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136(4):602-6.
2. Hickman RO, Buckner CD, Clift RA, Sandres JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148(6):871-5.
3. Gyves JW, Ensminger WD, Niederhuber JE, et al. A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA 1984;251(19):2538-41.
4. Freytes CO, Reid P, Smith KL, Long-term experience with a totally implanted catheter system in cancer patients. J Surg Oncol. 1990;45(2):99-102.
5. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol. 1989;25(6):939-44.
6. Capaccioli L, Nistri M, Distante V, Rontini M, Manetti A, Stecco A. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques]. Posizionamento e gestione dei sistemi per accesso venoso cetrale a lungo termine: contributo della diagnostica per immagini. Radiol Med (Torino). 1998;96(4):369-74.
7. Cohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies. Gynecol Oncol. 2001;83(3):533-6.
8. Herrmann KA, Waggershauser T, Helmberger T, Heinemann V, Sittek H, Reiser M. [Percutaneous interventional radiologic implantation of intravenous port-catheter systems]. Interventionell-radiologische perkutane Implantation intravenöser Port-Katheter-Systeme. Radiologe. 1999;39(9):777-82.
9. Campbell T. Central venous catheter management in patients with cancer. Int J Palliat Nurs. 2000;6(7):331-7.
10. Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE. Longterm central venous access in gynecologic cancer patients. J Am Coll Surg. 2000;191(4):403-9.
11. Abrahm JL, Mullen JL. A prospective study of prolonged central venous access in leukemia. JAMA. 1982;248(21):2868-73.
12. Costantini R, Napolitano L, Scurti D, Innocenti P. [Totally implantable central venous systems in neoplastic patients]. I sistemi venosi centrali totalmente impiantabili nei pazientí neoplastici. Ann Ital Chir. 1997;68(3):357-60.
13. Jaeger K, Osthaus A, Heine J, et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemotherapy. 2001;47(1):50-5.
14. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect. 1990;15(1):95-102.
15. Ballarini C, Intra M, Pisani Ceretti A, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology. 1999;56(2):97-102
16. Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol. 1999;20(3):187-91.
17. Douard MC, Ardoin C, Payri L, Tarot JP. [Infectious complications of long term intravenous devices: incidence, risk factors, diagnostic tools]. Complications infectieuses des dispositifs intraveineux de longue durée: incidence, facteurs de risque, moyens diagnostiques. Pathol Biol (Paris). 1999;47(3):288-91.
18. Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet. 1999;354(9184):1071-7.
19. Groebli Y, Bartolomei J, Wuthrich P, Callewaert G, Tschantz P, Piguet D. [Post-mortem evaluation following oncologic treatment of the functional and bacteriologic status of 25 permanent venous access devices]. Evaluation post-mortem après traitement oncologique de l'état fonctionnel et bactériologique de 25 accès veineux permanents. Schweiz Med Wochenschr. 1998;128(36):1334-8.
20. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168(2):400-7.
21. Astagneau P, Maugat S, Tran-Minh T. et al. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol. 1999;20(7);494-8.
22. Kappers-Klunne MC, Degener JE, Stijnen T, Abels J. Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infections. Cancer 1989;64(8):1747-52.
23. Hanna HA, Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol. 2001;22(3):165-6.
24. Balestreri L, De Cicco M, Matovic M, Coran F, Morassut S. Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study. Eur J Radiol. 1995;20(2):108-11.
25. Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian venous thrombosis. Am J Med. 1993;95(4):419-23.
26. Pintor Holguín E, Sáez Noguero F, Piret Ceballos MV, et al. [Axillary-subclavian thrombosis: review of its etiology and features in recent years]. Thrombosis axilosubclavia: revisión de la etiología y características en los últimos añ os. An Med Interna. 1997;14(2):67-70.
27. De Cicco M, Matovic M, Balestreri L, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res. 1997;86(2):101-13.
28. Conlan MG, Haire WD, Lieberman RP, Lund G, Kessinger A, Armitage JO. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell trasplantation. Bone Marrow Transplant. 1991;7(3):235-40.
29. Monreal M, Davant E. Thrombotic complications of central venous catheters in cancer patients. Acta Haematol. 2001;106(1-2):69-72.
30. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relatioship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994;271(13):1014-6.
31. Rodenhuis S, van't Hek LG, Vlasveld LT, Kroger R, Dubbelman R, van Tol RG. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator. Thorax. 1993;48(5):558-9.
32. Bothe A, Piccione W, Ambrosino JJ, Benotti PN, Lokich JJ. Implantable central venous access system. Am J Surg. 1984;147(4):565-9.
33. Lokich JJ, Bothe A, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol. 1985;3(5):710-7.
34. Harvey WH, Pick TE, Reed K, Solenberger RI. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet. 1989;169(6):495-500.
35. Torramadé JR, Cienfuegos JA, Hernández JL, et al. The complications of central venous access systems: a study of 218 patients. Eur J Surg. 1993;159(6-7):323-7.
36. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998;9(7):767-73.